Skip to main content

CPS TECHNOLOGIES CORP/DE/

For the period ended Jun 28, 2025. Filed Aug 1, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 28, 2025 · Filed Aug 1, 2025

CPSH$3.83+6.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. FINANCIAL STATEMENTS (Unaudited)

Balance Sheets (Unaudited)

June 28, 2025December 28, 2024
ASSETS
Current assets:
Cash and cash equivalents$2,374,037$3,280,687
Marketable securities, at fair value1,044,9251,031,001
Accounts receivable-trade5,602,7034,858,208
Accounts receivable-other416,029177,068
Inventories, net5,198,2464,331,066
Prepaid expenses and other current assets263,636480,986
Total current assets14,899,57614,159,016
Property and equipment:
Production equipment10,659,94810,382,379
Furniture and office equipment910,310891,921
Leasehold improvements997,830997,830
Total cost12,568,08812,272,130
Accumulated depreciation and amortization(10,698,945)(10,377,756)
Construction in progress78,834108,874
Net property and equipment1,947,9772,003,248
Intangible assets21,363-
Right-of-use lease asset108,000186,000
Deferred taxes, net2,392,8542,528,682
Total Assets$19,369,77018,876,946
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Note payable, current portion-8,130
Accounts payable3,286,2233,053,712
Accrued expenses1,036,463913,279
Deferred revenue30,384172,429
Lease liability, current portion108,000160,000
Total current liabilities4,461,0704,307,550
Deferred revenue – long term31,27731,277
Long term lease liability-26,000
Total liabilities4,492,3474,364,827
Commitments & Contingencies
Stockholders’ equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 14,661,487 shares; outstanding 14,525,960 shares at each June 28, 2025 and December 28, 2024146,615146,615
Additional paid-in capital40,751,92740,580,387
Accumulated other comprehensive income9,46915,500
Accumulated deficit(25,690,450)(25,890,245)
Less cost of 135,527 common shares repurchased at each June 28, 2025 and December 28, 2024(340,138)(340,138)
Total stockholders’ equity14,877,42314,512,119
Total liabilities and stockholders’ equity$19,369,770$18,876,946

Statements of Operations and Other Comprehensive Income (Loss) (Unaudited)

Three Months EndedSix Months Ended
June 28,June 29,June 28,June 29,
2025202420252024
Product sales$8,078,657$5,030,313$15,584,578$10,942,947
Cost of product sales6,742,3415,260,30513,017,26110,266,629
Gross profit1,336,316(229,992)2,567,317676,318
Selling, general, and administrative expenses1,199,3891,084,9952,300,7392,250,917
Income (loss) from operations136,927(1,314,987)266,578(1,574,599)
Other income, net19,02590,85169,501170,021
Net income (loss) before income taxes155,952(1,224,136)336,079(1,404,578)
Income tax provision (benefit)52,119(269,832)136,284(307,120)
Net income (loss)$103,833$(954,304)$199,795$(1,097,458)
Other comprehensive income
Net unrealized gains on available for sale securities8,1698,70110,2068,701
Reclassification adjustment for gains included in net income--(16,237)-
Total other comprehensive income8,1698,701(6,031)8,701
Comprehensive income (loss)112,002(945,603)193,764(1,088,757)
Net income (loss) per basic common share$0.01$(0.07)$0.01$(0.08)
Weighted average number of basic common shares outstanding14,525,96014,519,21514,525,96014,519,215
Net income (loss) per diluted common share$0.01$(0.07)$0.01$(0.08)
Weighted average number of diluted common shares outstanding14,577,43314,519,21514,560,67214,519,215

CPS TECHNOLOGIES CORP.

STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED JUNE 28, 2025 AND JUNE 29, 2024

Common Stock
Number of shares issuedPar ValueAdditional paid-in capitalAccumulated other comprehensive incomeAccumulated deficitStock repurchasedTotal stockholders’ equity
Balance at March 29, 202514,661,487$146,615$40,702,574$1,300$(25,794,283)$(340,138)$14,716,068
Share-based compensation expense--49,353---49,353
Other comprehensive income---8,169--8,169
Net loss----103,833-103,833
Balance at June 28, 202514,661,487$146,615$40,751,927$9,469$(25,690,450)$(340,138)$14,877,423
Common Stock
Number of shares issuedPar ValueAdditional paid-in capitalAccumulated other comprehensive incomeAccumulated deficitStock repurchasedTotal stockholders’ equity
Balance at December 28, 202414,661,487$146,615$40,580,387$15,500$(25,890,245)$(340,138)$14,512,119
Share-based compensation expense--171,540---171,540
Net unrealized gains on available for sale securities---10,206--10,206
Reclassification adjustment for gains included in net income---(16,237)--(16,237)
Net income----199,795-199,795
Balance at June 28, 202514,661,487$146,615$40,751,927$9,469$(25,690,450)$(340,138)$14,877,423
Common Stock
Number of shares issued · Par Value · Additional paid-in capital · Accumulated other comprehensive income · Accumulated deficit · Stock repurchased · Total stockholders’ equity
Balance at March 30, 202414,601,487$146,015$40,341,855$-$(22,897,950)$(250,138)$17,339,782
Share-based compensation expense--44,480---44,480
Other comprehensive income---8,701--8,701
Net loss----(954,304)-(954,304)
Balance at June 29, 202414,601,487$146,015$40,386,335$8,701$(23,852,254)$(250,138)$16,438,659
Common Stock
Number of shares issued · Par Value · Additional paid-in capital · Accumulated other comprehensive income · Accumulated deficit · Stock repurchased · Total stockholders’ equity
Balance at December 30, 202314,601,487$146,015$40,180,893$-$(22,754,796)$(250,138)$17,321,974
Share-based compensation expense--205,442---205,442
Other comprehensive income---8,701--8,701
Net loss----(1,097,458)-(1,097,458)
Balance at June 29, 202414,601,487$146,015$40,386,335$8,701$(23,852,254)$(250,138)$16,438,659

Statements of Cash Flows (Unaudited)

Six Months Ended
June 28,June 29,
20252024
Cash flows from operating activities:
Net income (loss)$199,795$(1,097,458)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization321,189237,954
Share-based compensation171,540205,442
Realized gain on sale of marketable securities(12,183)-
Deferred taxes135,828(307,576)
Changes in:
Accounts receivable-trade(744,495)324,862
Accounts receivable-other(238,961)(115,157)
Inventories(867,180)460,252
Prepaid expenses and other current assets217,350(90,306)
Accounts payable232,51152,788
Accrued expenses123,184(403,284)
Deferred revenue(142,045)(186,177)
Net cash used in operating activities(603,467)(918,660)
Cash flows from investing activities:
Purchases of property and equipment(265,918)(815,720)
Acquisition cost of patents and trademarks(21,363)-
Proceeds from sale of marketable securities518,000-
Purchase of marketable securities(525,772)(750,000)
Net cash used in investing activities(295,053)(1,565,720)
Cash flows from financing activities:
Payments on note payable(8,130)(23,002)
Net cash used in financing activities(8,130)(23,002)
Net decrease in cash and cash equivalents(906,650)(2,507,382)
Cash and cash equivalents at beginning of period3,280,6878,813,626
Cash and cash equivalents at end of period$2,374,037$6,306,244
Supplemental disclosures of cash flows information:
Cash paid for interest261,465

Notes to Financial Statements

(Unaudited)

(1) Nature of Business

CPS Technologies Corporation (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive, defense and other industries. The Company’s primary advanced material solution is metal-matrix composites ("MMC") which are a combination of metal and ceramic.

CPS also assembles housings and packages for hybrid circuits. These housings and packagesmayinclude components made of metal-matrix composites or theymayinclude components made of more traditional materials such as aluminum.

Using its proprietary MMC technology, the Company also produces light-weight armor, particularly for extreme environments and heavy threat levels.

The Company also engages in research and development, in some cases government funded and in others internally funded, focused on developing new products in response to customer requirements. These products expand our offerings in existing markets and enable penetration into new markets.

(2) Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form10-Q, these notes are condensed and donot contain all disclosures required by generally accepted accounting principles.

The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.

The Company’s balance sheet atDecember 28, 2024has been derived from the audited financial statements at that date, but doesnot include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form10-K for the year endedDecember 28, 2024and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.cpstechnologysolutions.com.

The results of operations for interim periods arenot necessarily indicative of the results to be expected for the full year.

(3) Marketable Securities

Investments consist of U.S. Treasury Bills with maturities up to one year. Since it is not currently managements intention to hold these debt securities until the maturity dates, these have been classified as available-for-sale (“AFS”) and are recorded on the balance sheet at fair value, with changes in fair value recorded as a component of other comprehensive income.

(4) Fair value ofMarketable Securities

ASC 820,Fair Value Measurements (“ASC 820”) states that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The three-tiered fair value hierarchy, which prioritizes which inputs should be used in measuring fair value, is comprised of: (Level I) observable inputs such as quoted prices in active markets; (Level II) inputs other than quoted prices in active markets that are observable either directly or indirectly and (Level III) unobservable inputs for which there is little or no market data. The fair value hierarchy requires the use of observable market data when available in determining fair value. CPS’ marketable securities consist solely of US Government bonds with a maturity of 12 months or less and which fall under Level II of the fair value hierarchy. The value of these bonds as of June 28, 2025 was $1,044,925 and was $1,031,001 as of December 28, 2024.

June 28, 2025December 28, 2024
Cost basis$1,033,947$1,015,501
Unrealized gain10,97815,500
Total fair value$1,044,925$1,031,001

(5) Net Income Per Common and Common Equivalent Share

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share is calculated by dividing net income by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive. Had there been a profit in Q2 and year to date in 2024, the dilutive effect would have been 29,254 shares and 50,607 shares, respectively.

The following table presents the calculation of both basic and diluted EPS:

Three Months EndedSix Months Ended
June 28,June 29,June 28,June 29,
2025202420252024
Basic EPS Computation:
Numerator:
Net income (loss)$103,833$(954,304)$199,795$(1,097,458)
Denominator:
Weighted average
Common shares
Outstanding14,525,96014,519,21514,525,96014,519,215
Basic EPS$0.01$(0.07)$0.01$(0.08)
Diluted EPS Computation:
Numerator:
Net income (loss)$103,833$(954,304)$199,795$(1,097,458)
Denominator:
Weighted average
Common shares
Outstanding14,525,96014,519,21514,525,96014,519,215
Dilutive effect of stock options51,473-34,712-
Total Shares14,577,43314,519,21514,560,67214,519,215
Diluted EPS$0.01$(0.07)$0.01$(0.08)

(6) Commitments & Contingencies

Commitments

Operating Leases

The Company hasone real estate lease expiring inFebruary 2026.CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration.None of these equipment leases have been capitalized as the Company elected an accounting policy for short-term leases, which allows lessees to avoid recognizing right-of-use assets and liabilities for leases with terms of12 months or fewer.

The real estate lease expiring in2026 (the “Norton facility lease”) is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized based on the present value of lease payments over the lease term using the Company’s incremental borrowing rate at commencement date. The Company’s lease agreements donot contain any material residual value guarantees or material restrictive covenants.

The Norton facility lease comprises approximately 38 thousand square feet. The lease is triple net lease wherein the Company is responsible for payment of all real estate taxes, operating costs and utilities. The Company also has an option to renew the lease starting inMarch 2026through*February 2032.*The Company is not reasonably certain these extensions will be exercised at this time, and therefore are not included in the lease asset or liability. Annual rental payments range from $160 thousand to $165 thousand through maturity.

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating lease as ofJune 28, 2025:

(Dollars in Thousands)June 28, 2025
Maturity of capitalized lease liabilitiesLease payments
202583
202628
Total undiscounted operating lease payments$111
Less: Imputed interest(3)
Present value of operating lease liability$108
Balance Sheet Classification
Current lease liability$108
Long-term lease liability-
Total operating lease liability$108
Other Information
Remaining lease term for capitalized operating lease (months)8
Discount rate for capitalized operating leases6.6%

Operating Lease Costs and Cash Flows

Operating lease cost and cash paid was $41 thousand during thesecond quarter of2025 and $83 thousand for thesix months ended*June 28, 2025.*These costs are related to its long-term operating lease. All other short-term leases were immaterial.

Finance Leases

The company doesnot have any finance leases.

(7) Share-Based Payments

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

During the quarter endedJune 28, 2025,no stock options were granted to employees under the Company’s2020 Equity Incentive Plan Stock Incentive Plan (the “Plan”) andno stock options were granted to outside directors during the quarter endedJune 28, 2025. For the six months ended June 28, 2025 a total of 115,000 stock options and 75,000 stock options were granted to employees and directors, respectively. During the quarter endedJune 29, 2024,no stock options were granted to employees under the Company’s2020 Equity Incentive Plan Stock Incentive Plan (the “Plan”) andno stock options were granted to outside directors during the quarter endedJune 29, 2024. For the six months ended June 29, 2024 a total of 135,500 stock options and 75,000 stock options were granted to employees and directors, respectively

During thethree andsix months endedJune 28, 2025,there wereno options exercised and corresponding shares issued. During thethree andsix months ended*June 29, 2024,*there were no options exercised and corresponding shares issued.

During thethree andsix months endedJune 28, 2025,the Company didnot repurchase any shares for employees to facilitate their exercise of stock options. During thethree andsix months ended*June 29, 2024,*the Company didnot repurchase any shares for employees to facilitate their exercise of stock options.

There were also 1,083,300 options outstanding at a weighted average price of $2.45 with a weighted average remaining term of 7.36 years as of*June 28, 2025,and there were 594,100 options exercisable at a weighted average price of $2.40 with a weighted average remaining term of 6.49 years as ofJune 28, 2025.The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As ofJune 28, 2025,there were 421,400 shares available for future grants under the 2020 Plan and 141,900 shares outstanding under the 2009 Plan. As ofJune 29, 2024,*there were 638,300 shares available for future grants under the 2020 Plan and 236,200 shares outstanding under the 2009 Plan.

As of*June 28, 2025,*there was $559 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 2.41 years.

During thethree andsix months ended*June 28, 2025,*the Company recognized $49,354 and $171,540, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

During thethree andsix months ended*June 29, 2024,*the Company recognized $44,480 and $205,442, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

(8) Inventories

Inventories consist of the following:

June 28,December 28,
20252024
Raw materials$2,719,237$2,625,305
Work in process2,678,7051,880,396
Finished goods351,716343,722
Total inventory5,749,6584,849,423
Reserve for obsolescence(551,412)(518,357)
Inventories, net$5,198,246$4,331,066

(9) Accrued Expenses

Accrued expenses consist of the following:

June 28,December 28,
20252024
Accrued legal and accounting$77,177$138,600
Accrued payroll and related expenses354,631254,737
Accrued product returns500,283429,617
Accrued other104,37290,325
$1,036,463$913,279

(10) Line of Credit

The Company has a $3.0 million revolving line of credit (LOC) with Rockland Trust Company. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of the National Prime Rate as published by the Wall Street Journal (7.5% atJune 28, 2025). On*June 28, 2025,*the Company had $0 of borrowings under this LOC and its borrowing base at the time would have permitted an additional $3.0 million to have been borrowed. The line of credit remains in effect and has been extended to August 5, 2025.

(11) Segment Reporting

The Company views its operations and manages its business asone segment. The Company produces and sells advanced material solutions, primarily metal matrix composites, to assemblers of high density electronics and other specialty components and subassemblies. The Company also assembles housings and packages for hybrid circuits, selling to the same customers mentioned above. These customers represent a single market or segment with similar stringent and well-defined requirements. The Company’s customers, in turn, sell the components and subassemblies which incorporate the products into many different end markets, however, these end markets aretwo tothree levels removed from the Company. The Company also sells armor strike faces to armor manufacturers, using the same manufacturing process used in its other product solutions. The Company makes operating decisions and assesses financial performance only for the Company as a whole and doesnot make operating decisions or assess financial performance by the end markets which ultimately use the products. Our chief operating decision maker (CODM) is Brian Mackey, our President and CEO. The Company's CODM regularly reviews financial information presented and does not evaluate the Company's operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.

The following table presents segment information for the Company's single reporting segment:

Three Months EndedSix Months Ended
June 28, 2025June 29, 2024June 28, 2025June 29, 2024
Product sales$8,078,657$5,030,313$15,584,578$10,942,947
Cost of product sales6,742,3415,260,30513,017,26110,266,629
Gross profit (loss)1,336,316(229,992)2,567,317676,318
Selling, general, and administrative expenses1,199,3891,084,9952,300,7392,250,917
Income (loss) from operations136,927(1,314,987)266,578(1,574,599)
Other income, net19,02590,85169,501170,021
Income (loss) before income taxes155,952(1,224,136)336,079(1,404,578)
Income tax provision (benefit)52,119(269,832136,284(307,120)
Net income (loss)$103,833$(954,304)$199,795$(1,097,458)

(12) Income Taxes

A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely thannot" that all or a portion of deferred tax assets willnot be realized. Management has determined that a valuation allowance is not needed as it expects that the deferred tax asset will be fully utilized.

For thethree and six months ended June 28, 2025 the deferred tax asset was decreased $52,119 and $135,828 for the estimated tax provision for Q2 and year to date net income, respectively.

(13) Subsequent Events: Enactment of the One Big Beautiful Bill Act

On July 4, 2025, the President signed into law the One Big Beautiful Bill Act (Public Law 119-21), which includes significant modifications to the Internal Revenue Code. The legislation permanently extends and modifies key provisions of the Tax Cuts and Jobs Act of 2017 and introduces new deductions and credits applicable to both individuals and businesses.

Key provisions relevant to the Company include:

***Restoration of Immediate Expensing for Domestic Research and Experimental ("R&E") Expenditures:***Effective for tax years beginning after December 31, 2024, domestic R&E expenditures may be immediately expensed under new Section 174A, reversing the prior capitalization and amortization requirement. This change may materially impact the Company’s deferred tax assets and current tax expense depending on the volume of qualifying expenditures.

It is anticipated that the unamortized Section 174 R&E expenditures at Q2 2025 will be expensed as follows (subject to further analyses and discussions):

20252026TotalRationale
Q3 2025899,728-899,728Expense remaining unamortized for 2025 and 37.5% of 2022-2024
Q4 2025187,193-187,193Expense 12.5% of 2022-2024
Q1 2026-187,193187,193Expense 12.5% of 2022-2024
Q2 2026-187,193187,193Expense 12.5% of 2022-2024
Q3 2026-187,193187,193Expense 12.5% of 2022-2024
Q4 2026-187,193187,193Expense 12.5% of 2022-2024
Totals1,086,921748,7721,835,693

***Enhancement of Section 179 Expensing:***The maximum Section 179 deduction is increased to $2.5 million, with a phase-out threshold beginning at $4 million. This expansion is expected to accelerate tax deductions for qualifying property and benefit capital investment strategies.

***Permanent Reinstatement of 100% Bonus Depreciation:***For qualified property acquired and placed in service after January 19, 2025, the Company may elect full expensing under Section 168(k), which is expected to accelerate tax deductions and reduce taxable income in applicable periods.

***Modifications to FDII (now FDDEI):***The deduction under Section 250 for foreign-derived intangible income is reduced to 33.34%, and eligibility criteria are narrowed. These changes may impact export-related tax incentives and deferred tax projections tied to U.S.-held IP.

The Company is currently evaluating the impact of these provisions on its financial statements and tax positions. While the changes are not expected to materially affect prior period results, they may influence future effective tax rates, deferred tax balances, and cash tax obligations. The Company will incorporate these changes into its tax planning and provision calculations for fiscal year 2025 and beyond. However, the full effect of these provisions will depend on the Company's future capital expenditures, R&E activities, financing arrangements, and international operations. The Company will incorporate these changes into its tax provision and planning beginning in fiscal year 2025.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.